Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery

REFERENCES

• Alexander H. R., Bartlett D. L., Libutti S. K., Fraker D. L., Moser T., Rosenberg S. A.. 1998. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. J. Clin. Oncol.. 16: 1479–1489. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Baban D. F.. 1998. Control of tumour vascular permeability. Ad. Drug Delivery Rev.. 34: 109–119. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bergqvist L., Sundberg R., Ryden S., Strand S. E.. 1987. The “critical colloid dose” in studies of reticuloendothelial function. J. Nucl. Med.. 28: 1424–1429. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bradfield J. W.. 1980. A new look at reticuloendothelial blockade. Br. J. Exp. Pathol.. 61: 617–623. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chandler J., Robinson N., Whiting K.. 2001. Handling false signals in gold-based tests. I.V.D. Technol.. 72, 2001. 34–35
   Google Scholar
• Cleland J. L.. 1997. Protein delivery from biodegradable microspheres. In Protein Delivery: Physical Systems, Sanders, Hendren, 1–43, New York, Plenum Press
   Google Scholar
• Creaven P. J., Plager J. E., Dupere S., Huben R. P., Takite H., Mittleman A., Proefrock A.. 1987. Phase I clinical trial of recombinant human tumor necrosis factor. Cancer Chemother. Pharmacol.. 20: 137–144. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Faraday M.. 1857. Experimental relations of gold (and other metals) to light. Philos. Trans. R. Soc. London. 14: 145–181
   Google Scholar
• Fraker D. L., Alexander H. R., Andrich M., Rosenberg S. A.. 1996. Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study. J. Clin. Oncol.. 14: 479–489. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Frens G.. 1972. Controlled nucleation for the regulation of particle size in monodisperse gold suspensions. Nature Phys. Sci.. 241: 20–22
   Web of Science ®Google Scholar
• Furman W. I., Strother D., McClain K., Bell B., Leventhol B., Pratt C. B.. 1993. Phase I clinical trial of recombinant human tumor necrosis factor in children with refractory solid tumors: A pediatric oncology group study. J. Clin. Oncol.. 11: 2205–2210. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hardonk M. J., Harms G., Koudstaal J.. 1985. Zonal heterogeneity of rat hepatocytes in the vivo uptake of 17 nm colloidal gold granules. Histochemistry. 83: 473–477. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Hermanson G. T.. 1996; Bioconjugate Techniques.. Academic Press, Inc., San Diego, California
   Google Scholar
• Horisberger M.. 1979. Evaluation of colloidal gold as a cytochemical marker for transmission and scanning electron microscopy. Biol. Cellulaire. 36: 253–258
   Google Scholar
• Illum L., Davis S. S., Muller R. H., Mak E., West P.. 1987. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer—poloxamine 908. Life Sci.. 40: 367–374. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Jain R., Shah N. H., Malick A. W., Rhodes C. T.. 1998. Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches. Drug Dev. Indust. Pharm.. 24: 703–727
   PubMed Web of Science ®Google Scholar
• Kristensen C. A., Nozue M., Boucher Y., Jain R. K.. 1996. Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts. Br. J. Cancer. 74: 533–536. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kurfurst M.. 1992. Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal. Biochem.. 200: 244–248. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lejeune F. J.. 1995. High dose recombinant tumour necrosis factor (rTNFα) administered by isolation perfusion for advanced tumors of the limbs: a model for biochemotherapy of cancer. Eur. J. Cancer. 3: 1009–1016. [CROSSREF]
   Google Scholar
• Maruyama K., Takizawa T., Takahashi N., Tagawa T., Nagaike K., Iwatsuru M.. 1998. Targeting efficiency of PEG-immunoliposome-conjugated antibodies at PEG terminals. Ad. Drug Delivery Rev.. 24: 235–242. [CROSSREF]
   Web of Science ®Google Scholar
• Maruyama K., Ishida O., Takizawa T., Moribe K.. 1999. Possibility of active targeting to tumor tissues with liposomes. Ad. Drug Delivery Rev.. 40: 89–102. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mirkin C. A., Letsinger R. L., Mucic R. C., Storhoff J. J.. 1996. A DNA based method for rationally assembling nanoparticles into macroscopic materials. Nature. 382: 607–609. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Moghimi S. M.. 1999. Re-establishing the long circulatory behaviour of poloxamine-coated particles after repeated intravenous administration: applications in cancer drug delivery and imaging. Biochim. Biophys. Acta. 1472: 399–403. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Moghimi S. M., Patel H. M.. 1998. Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system—the concept of tissue specificity. Ad. Drug Delivery Rev.. 32: 45–60. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Molema G., de, Leij L. F. M. H., Meijer D. K. F.. 1997. Tumor vascular endothelium: barrier or target in tumor directed drug delivery and immunotherapy. Pharm. Res.. 14: 2–38. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Müller R. H., Mäder K., Gohla S.. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur. J. Pharm. Biopharm.. 50: 161–177. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nafayasu A., Uchiyama K., Kiwada H.. 1999. The size of liposomes: a factor, which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Ad. Drug. 40: 75–87
   PubMed Web of Science ®Google Scholar
• Nedrebo T., Berg A., Reed R. K.. 1999. Effect of tumor necrosis factor-α, IL-1-β, and IL-6 on interstitial fluid pressure in rat skin. Am. J. Physiol.. 277. Heart Circ. Physiol.. 46: H1857–H1862. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Netti P. A., Hamberg L. M., Babich J. W., Kierstia D., Graham W., Hunter G. J., Wolf G. L., Fischnan A., Boucher Y., Jain R. K.. 1999. Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules. Proc. Natl. Acad. Sci. USA. 96: 3137–3142. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nuzzo R. G., Allara D. L.. 1983. Adsorption of Bifunctional Organic Disulfides on Gold Surfaces. J. Am. Chem. Soc.. 105: 4481–4483
   Web of Science ®Google Scholar
• Ogawa Y.. 1997. Injectable microcapsules prepared with biodegradable poly(α-hydroxy) acids for prolonged release of drugs. J. Biomater. Sci. Polymer Edn.. 8: 391–409
   PubMed Web of Science ®Google Scholar
• Papisov M. I.. 1998. Theoretical considerations of RES-avoiding liposomes: molecular mechanisms and chemistry of liposome interactions. Ad. Drug Delivery Rev.. 32: 119–138. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rafferty D. E., Elfaki M. G., Montgomery P. C.. 1996. Preparation and characterization of a biodegradable microparticle antigen/cytokine delivery system. Vaccine. 14: 532–538. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Redhead H. M., Davis S. S., Illum L.. 2001. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J. Control Release. 70: 353–363. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Renaud G., Hamilton R. L., Havel R.. 1989. Hepatic metabolism of colloidal gold-low-density lipoprotein complexes in the rat: evidence for bulk excretion of lyosomal contents into bile. Hepatology. 9: 380–392. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Root S. W., Andrews G. A., Knieseley R. M., Tyor M. P.. 1954. The distribution and radiation effects of intravenously administered colloidal Au 198 in man. Cancer. 7: 856–866. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rubin P., Levitt S. H.. 1964. The response of disseminated reticulum cell sarcoma to the intravenous injection of colloidal radioactive gold. J. Nuclear Med.. 5: 581–594
   PubMed Web of Science ®Google Scholar
• Schiller J. H., Storer B. E., Witt P. L., Alberti D., Tombes M. M. B., Arzoomanian R., Proctor R. A., McCarthy D., Brown R. R., Voss S. D., Remick S. C., Grem J. L., Borden E. C., Trump D. L.. 1991. Biological and clinical effects of intravenous tumor necrosis factor-a administered three times weekly. Cancer Res.. 51: 1651–1658. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stohrer M., Boucher Y., Stangassinger M., Jain R. K.. 2000. Oncotic pressure in solid tumors is elevated. Cancer Res.. 60: 4251–4255. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Taguchi T.. 1988. Phase I study of recombinant human tumor necrosis factor (rHuTNF-PT-050). Cancer Detect. Prev.. 12: 561–572. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Woodle M. C.. 1998. Controlling liposome blood clearance by surface grafted polymers. Ad. Drug Delivery Rev.. 32: 139–152. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zhang X. Y., Luck J., Derhirst M. W., Fan Yuan F.. 2000. Interstitial hydraulic conductivity in a fibrosarcoma. Am. J. Physiol. Heart Circ. Physiol.. 279: H2726–H2734. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar